Tosedostat and Cytarabine or Azacitidine in Treating Older Participants With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
Clinical trial NCT01636609 · TERMINATED
Trial details
- NCT number
- NCT01636609
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-20
- Primary completion
- 2019-07-04
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.